Literature DB >> 14613743

Decreased nocturnal standard deviation of averaged NN intervals. An independent marker to identify patients at risk in the Brugada Syndrome.

Jean-Sylvain Hermida1, Antoine Leenhardt, Bruno Cauchemez, Isabelle Denjoy, Geneviève Jarry, Fréderique Mizon, Paul Milliez, Jean-Luc Rey, Philippe Beaufils, Philippe Coumel.   

Abstract

AIMS: Risk-stratification of asymptomatic Brugada Syndrome (BS) patients remains a key-issue. A typical spontaneous BS-ECG pattern and ventricular tachycardia (VT)/ventricular fibrillation (VF) inducibility are two recognized risk markers. The aim of the study was to identify additional risk markers in asymptomatic BS. METHODS AND
RESULTS: We have compared Holter recordings in symptomatic and in asymptomatic patients with BS. Heart rate variability (HRV), QT-interval rate-dependence and ST-segment elevation (ST-SE) were analysed. The study population included 47 BS patients (M=36, mean age=45+/-13 years) with a malignant ventricular arrhythmia in 11 cases, an unexplained syncope in 10 cases and no symptoms in the remaining 26 cases. A typical spontaneous BS-ECG was present in 21 cases and a drug-induced BS-ECG in 26 cases. A downward trend of the time domain variables of HRV was observed. During the nocturnal period, standard deviation (SD) of the 5min averaged NN intervals (SDANN) (46+/-13 vs 57+/-18ms, P=0.02) and ultra low frequency component (3287+/-2312 vs 5030+/-3270 ms(2), P=0.04) were significantly lower in symptomatic versus asymptomatic patients. In contrast, no difference was found in QT-interval rate dependence and in ST-SE. At multivariate logistic regression, VT/VF inducibility, typical spontaneous BS-ECG and a decreased nocturnal SDANN were associated with arrhythmic events (P=0.003).
CONCLUSIONS: A decreased nocturnal SDANN was an independent marker of arrhythmic events in these BS patients.

Entities:  

Mesh:

Year:  2003        PMID: 14613743     DOI: 10.1016/j.ehj.2003.08.019

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Brugada syndrome.

Authors:  Johnson Francis; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2005-05-25       Impact factor: 4.164

2.  The utility of T-wave alternans during the morning in the summer for the risk stratification of patients with Brugada syndrome.

Authors:  Shogo Sakamoto; Masahiko Takagi; Jun Kakihara; Yusuke Hayashi; Atsushi Doi; Kenichi Sugioka; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-08-01       Impact factor: 2.037

3.  Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.

Authors:  Shogo Sakamoto; Masahiko Takagi; Hiroaki Tatsumi; Atsushi Doi; Kenichi Sugioka; Akihisa Hanatani; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2015-05-20       Impact factor: 2.037

4.  Multivariate classification of Brugada syndrome patients based on autonomic response to exercise testing.

Authors:  Mireia Calvo; Daniel Romero; Virginie Le Rolle; Nathalie Béhar; Pedro Gomis; Philippe Mabo; Alfredo I Hernández
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.